Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thromboembolism of Vein VTE in Colorectal Cancer 1 Thromboembolism 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Kidney Neoplasms 1 Fatigue 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1

Interventions

aldesleukin 43 Sunitinib 42 Cyclophosphamide 30 Nivolumab 29 pembrolizumab 27 Everolimus 27 Interferon-alpha 25 Bevacizumab 23 Sorafenib 22 Interleukin-2 20 fludarabine phosphate 19 Radiotherapy 18 Ipilimumab 18 Filgrastim 18 Axitinib 18 Gene Expression Profiling 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 cabozantinib 14 Radiosurgery 13 fludarabine 11 Doxorubicin 11 Carboplatin 11 Blood Specimen Collection 11 temsirolimus 10 atezolizumab 9 Immunohistochemistry 9 Etoposide 9 Chemotherapy, Adjuvant 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × isoquercitrin × Clear all

NCT02446795 2017-01-18

QUASAR

Consorzio Oncotech

Phase 1/2 Unknown

Carcinoma, Renal Cell, Fatigue, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡